Clinical progression of Alzheimer’s disease is characterized by impairment in cognition and function. The objective of the recent study published in the JPAD Journ Prevention Alzheiemr’s diseases is to assess the relationship between cognitive and functional impairment in mild Alzheimer’s… Continue Reading →
This symposium was presented at ICFSR 2018 (Miami Beach, USA, 1-3 March 2018)
Eisai and Biogen announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early Alzheimer’s disease. The study achieved statistical significance on key predefined endpoints evaluating efficacy at 18 months… Continue Reading →
© 2026 Aging-news